2009Unpublished venueRequires access

Iron Metabolism and Hepcidin

Hiroshi Kawabata

Open publisher page 0 citations

Abstract

Summary Iron is essential for a variety of cellular functions, but it can cause tissue damage when present in excess. Due to its dual nature, the amount of iron in the body should be strictly controlled. One of the key molecules for maintaining iron homeostasis in the body is hepcidin, a peptide hormone mainly produced in the liver. Expression of hepcidin is upregu- lated by iron loading and inflammatory cytokines such as interleukin-6, and down-regulated by hypoxia and erythropoie- tic stimuli. Hepcidin decreases both iron absorption from the intestine and iron release from macrophages through down- regulation of ferroportin, the only iron exporter of the cells. HFE , TFR2 (transferrin receptor 2) and HJV (hemojuvelin) are expressed in the liver, and these are related to the iro ns ensing machinery. Mutations of one of these genes or HAMP (hepcidin) gene cause down-regulation of hepcidin expression ,r esulting in increased iron absorption from the intestine and iron accumulation in the body (hereditar yh emochromatosis). In contrast, mutations of TMPRSS6 (matriptase-2) gene cause an increase of hepcidin expression, resulting in hereditary iron deficiency anemia. Hepcidin is also upregulated in chronic inflammation, causing anemia of chronic disease. In this review, I will attempt to provide an integrated view of physiology and pathophysiology of iron metabolism in the body by focusing on hepcidin.

About this research paper

What this paper is about

Summary Iron is essential for a variety of cellular functions, but it can cause tissue damage when present in excess. Due to its dual nature, the amount of iron in the body should be strictly controlled. One of the key molecules for maintaining iron homeostasis in the body is hepcidin, a peptide hormone mainly produced in the liver. Expression of hepcidin is upregu- lated by iron loading and inflammatory cytokines such as interleukin-6, and down-regulated by hypoxia and erythropoie- tic stimuli. Hepcidin decreases both iron absorption from the intestine and iron release from macrophages through down- regulation of ferroportin, the only iron exporter of the cells. HFE , TFR2 (transferrin receptor 2) and HJV (hemojuvelin) are expressed in the liver, and these are related to the iro ns ensing machinery. Mutations of one of these genes or HAMP (hepcidin) gene cause down-regulation of hepcidin expression ,r esulting in increased iron absorption from the intestine and iron accumulation in the body (hereditar yh emochromatosis). In contrast, mutations of TMPRSS6 (matriptase-2) gene cause an increase of hepcidin expression, resulting in hereditary iron deficiency anemia. Hepcidin is also upregulated in chronic inflammation, causing anemia of chronic disease. In this review, I will attempt to provide an integrated view of physiology and pathophysiology of iron metabolism in the body by focusing on hepcidin.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Summary Iron is essential for a variety of cellular functions, but it can cause tissue damage when present in excess. Due to its dual nature, the amount of iron in the body should be strictly controlled. One of the key molecules for maintaining iron homeostasis in the body is hepcidin, a peptide hormone mainly produced in the liver. Expression of hepcidin is upregu- lated by iron loading and inflammatory cytokines such as interleukin-6, and down-regulated by hypoxia and erythropoie- tic stimuli. Hepcidin decreases both iron absorption from the intestine and iron release from macrophages through down- regulation of ferroportin, the only iron exporter of the cells. HFE , TFR2 (transferrin receptor 2) and HJV (hemojuvelin) are expressed in the liver, and these are related to the iro ns ensing machinery. Mutations of one of these genes or HAMP (hepcidin) gene cause down-regulation of hepcidin expression ,r esulting in increased iron absorption from the intestine and iron accumulation in the body (hereditar yh emochromatosis). In contrast, mutations of TMPRSS6 (matriptase-2) gene cause an increase of hepcidin expression, resulting in hereditary iron deficiency anemia. Hepcidin is also upregulated in chronic inflammation, causing anemia of chronic disease. In this review, I will attempt to provide an integrated view of physiology and pathophysiology of iron metabolism in the body by focusing on hepcidin.

Key concepts: Hepcidin, Ferroportin, HAMP, DMT1, Hereditary hemochromatosis, Hemochromatosis, Anemia of chronic disease, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Iron Metabolism and Hepcidin — Research Paper | ScholarLens